Combining single-cell resolution with comprehensive biology from genotype to phenotype. Mission Bio is accelerating the discovery, development and delivery of precision medicine.
Accelerate to discover
Related topics
The Mission Bio Tapestri platform was utilized to overcome the limitations of bulk sequencing in solid tumors with low cellularity, allowing high-throughput targeted snDNA-seq.
Method: 38 snap-frozen tissue samples from 16 pancreatic ductal adenocarcinoma (PDAC) patients underwent an automated 30-minute nuclei extraction. The single nuclei were then encapsulated using the Tapestri microfluidic microdroplet platform for targeted multiplex PCR amplification and library preparation.
Detection & Benefits: Tapestri bypassed the “mixed signals” of bulk sequencing caused by high stromal contamination. It successfully captured an average of 2,867 single nuclei per sample with >80X coverage depth. This enabled the precise resolution of subclones, accurate tracking of phylogenetic evolution from primary tumors to metastases, and the clear detection of zygosity and co-occurrence of key driver mutations (e.g., KRAS, TP53, SMAD4) at single-cell resolution.
Related technologies: Gene discovery and analysis
Combining single-cell resolution with comprehensive biology from genotype to phenotype. Mission Bio is accelerating the discovery, development and delivery of precision medicine.
More info at:
https://missionbio.com/